Lopinavir/Ritonavir
Tier C — Watch / tradeLopinavir/Ritonavir
Targets：HIV-1 protease
Brand：Aluvia, Lopimune, Kaletra, カレトラ
Indications (approved)：HIV infection
Regional status
Factories producing this API10
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
10 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates
Frequently asked questions
What are the approved indications of Lopinavir/Ritonavir?
Approved indications include: HIV infection.
When does the Lopinavir/Ritonavir patent expire?
No public expiry year is available for Lopinavir/Ritonavir yet; this page updates once verified.
How do I get a quote for Lopinavir/Ritonavir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27